Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tizanidine premedication for blood loss and surgical field quality in endoscopic sinus surgery
IRCT20160430027677N12Phase 3Completed
- Sponsor
- Urmia University of Medical Sciences
- Start
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of tizanidine in rhinosinusitis (2 arms), sponsored by Urmia University of Medical Sciences. Primary endpoint: Amount of bleeding. Started May 2016; status: completed.
02
Drugs
tizanidine
03
Conditions
rhinosinusitis
Beyond the preview
Go deeper on IRCT20160430027677N12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160430027677N12.